[1] Weinberg AD. OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines. Trends Immunol, 2002, 23: 102-109.
[2] Rogers PR, Song J, Grauaglia I, et al.OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity, 2001, 15:445-455.
[3] Maxwell JR, Weinberg A, Prell RA, et al.Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J Immunol,2000, 164:107-112.
[4] Aten J, Roos A, Claessen N, et al. Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis. J Am Soc Nephrol, 2000, 11: 1426-1438.
[5] Taylor L, Schwarz H. Identification of a soluble OX40 isoform: development of a specific and quantitative immunoassay. J Immunol Methods, 2001, 255 (1-2):67-72. |
